Global Migraine Market Research Report 2024(Status and Outlook)
Report Overview:
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
The Global Migraine Market Size was estimated at USD 5769.08 million in 2023 and is projected to reach USD 9257.00 million by 2029, exhibiting a CAGR of 8.20% during the forecast period.
This report provides a deep insight into the global Migraine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Migraine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Migraine market in any manner.
Global Migraine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GlaxoSmithKline
Allergan
Amgen
Eli Lilly
Teva Pharma
Biohaven Pharma
Abbott Laboratories
Johnson & Johnson
Valeant Pharma
Market Segmentation (by Type)
Oral
Injectable
Nasal Sprays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Home Care
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Migraine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
The Global Migraine Market Size was estimated at USD 5769.08 million in 2023 and is projected to reach USD 9257.00 million by 2029, exhibiting a CAGR of 8.20% during the forecast period.
This report provides a deep insight into the global Migraine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Migraine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Migraine market in any manner.
Global Migraine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GlaxoSmithKline
Allergan
Amgen
Eli Lilly
Teva Pharma
Biohaven Pharma
Abbott Laboratories
Johnson & Johnson
Valeant Pharma
Market Segmentation (by Type)
Oral
Injectable
Nasal Sprays
Others
Market Segmentation (by Application)
Hospitals
Clinics
Home Care
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Migraine Market
- Overview of the regional outlook of the Migraine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Migraine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Migraine
1.2 Key Market Segments
1.2.1 Migraine Segment by Type
1.2.2 Migraine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MIGRAINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Migraine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Migraine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MIGRAINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Migraine Sales by Manufacturers (2019-2024)
3.2 Global Migraine Revenue Market Share by Manufacturers (2019-2024)
3.3 Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Migraine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Migraine Sales Sites, Area Served, Product Type
3.6 Migraine Market Competitive Situation and Trends
3.6.1 Migraine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Migraine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MIGRAINE INDUSTRY CHAIN ANALYSIS
4.1 Migraine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MIGRAINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MIGRAINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Migraine Sales Market Share by Type (2019-2024)
6.3 Global Migraine Market Size Market Share by Type (2019-2024)
6.4 Global Migraine Price by Type (2019-2024)
7 MIGRAINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Migraine Market Sales by Application (2019-2024)
7.3 Global Migraine Market Size (M USD) by Application (2019-2024)
7.4 Global Migraine Sales Growth Rate by Application (2019-2024)
8 MIGRAINE MARKET SEGMENTATION BY REGION
8.1 Global Migraine Sales by Region
8.1.1 Global Migraine Sales by Region
8.1.2 Global Migraine Sales Market Share by Region
8.2 North America
8.2.1 North America Migraine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Migraine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Migraine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Migraine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Migraine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Migraine Basic Information
9.1.2 Pfizer Migraine Product Overview
9.1.3 Pfizer Migraine Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Migraine SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Migraine Basic Information
9.2.2 GlaxoSmithKline Migraine Product Overview
9.2.3 GlaxoSmithKline Migraine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Migraine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Allergan
9.3.1 Allergan Migraine Basic Information
9.3.2 Allergan Migraine Product Overview
9.3.3 Allergan Migraine Product Market Performance
9.3.4 Allergan Migraine SWOT Analysis
9.3.5 Allergan Business Overview
9.3.6 Allergan Recent Developments
9.4 Amgen
9.4.1 Amgen Migraine Basic Information
9.4.2 Amgen Migraine Product Overview
9.4.3 Amgen Migraine Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Migraine Basic Information
9.5.2 Eli Lilly Migraine Product Overview
9.5.3 Eli Lilly Migraine Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Recent Developments
9.6 Teva Pharma
9.6.1 Teva Pharma Migraine Basic Information
9.6.2 Teva Pharma Migraine Product Overview
9.6.3 Teva Pharma Migraine Product Market Performance
9.6.4 Teva Pharma Business Overview
9.6.5 Teva Pharma Recent Developments
9.7 Biohaven Pharma
9.7.1 Biohaven Pharma Migraine Basic Information
9.7.2 Biohaven Pharma Migraine Product Overview
9.7.3 Biohaven Pharma Migraine Product Market Performance
9.7.4 Biohaven Pharma Business Overview
9.7.5 Biohaven Pharma Recent Developments
9.8 Abbott Laboratories
9.8.1 Abbott Laboratories Migraine Basic Information
9.8.2 Abbott Laboratories Migraine Product Overview
9.8.3 Abbott Laboratories Migraine Product Market Performance
9.8.4 Abbott Laboratories Business Overview
9.8.5 Abbott Laboratories Recent Developments
9.9 Johnson and Johnson
9.9.1 Johnson and Johnson Migraine Basic Information
9.9.2 Johnson and Johnson Migraine Product Overview
9.9.3 Johnson and Johnson Migraine Product Market Performance
9.9.4 Johnson and Johnson Business Overview
9.9.5 Johnson and Johnson Recent Developments
9.10 Valeant Pharma
9.10.1 Valeant Pharma Migraine Basic Information
9.10.2 Valeant Pharma Migraine Product Overview
9.10.3 Valeant Pharma Migraine Product Market Performance
9.10.4 Valeant Pharma Business Overview
9.10.5 Valeant Pharma Recent Developments
10 MIGRAINE MARKET FORECAST BY REGION
10.1 Global Migraine Market Size Forecast
10.2 Global Migraine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Migraine Market Size Forecast by Country
10.2.3 Asia Pacific Migraine Market Size Forecast by Region
10.2.4 South America Migraine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Migraine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Migraine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Migraine by Type (2025-2030)
11.1.2 Global Migraine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Migraine by Type (2025-2030)
11.2 Global Migraine Market Forecast by Application (2025-2030)
11.2.1 Global Migraine Sales (K Units) Forecast by Application
11.2.2 Global Migraine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Migraine
1.2 Key Market Segments
1.2.1 Migraine Segment by Type
1.2.2 Migraine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MIGRAINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Migraine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Migraine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MIGRAINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Migraine Sales by Manufacturers (2019-2024)
3.2 Global Migraine Revenue Market Share by Manufacturers (2019-2024)
3.3 Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Migraine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Migraine Sales Sites, Area Served, Product Type
3.6 Migraine Market Competitive Situation and Trends
3.6.1 Migraine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Migraine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MIGRAINE INDUSTRY CHAIN ANALYSIS
4.1 Migraine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MIGRAINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MIGRAINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Migraine Sales Market Share by Type (2019-2024)
6.3 Global Migraine Market Size Market Share by Type (2019-2024)
6.4 Global Migraine Price by Type (2019-2024)
7 MIGRAINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Migraine Market Sales by Application (2019-2024)
7.3 Global Migraine Market Size (M USD) by Application (2019-2024)
7.4 Global Migraine Sales Growth Rate by Application (2019-2024)
8 MIGRAINE MARKET SEGMENTATION BY REGION
8.1 Global Migraine Sales by Region
8.1.1 Global Migraine Sales by Region
8.1.2 Global Migraine Sales Market Share by Region
8.2 North America
8.2.1 North America Migraine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Migraine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Migraine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Migraine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Migraine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Migraine Basic Information
9.1.2 Pfizer Migraine Product Overview
9.1.3 Pfizer Migraine Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Migraine SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Migraine Basic Information
9.2.2 GlaxoSmithKline Migraine Product Overview
9.2.3 GlaxoSmithKline Migraine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Migraine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Allergan
9.3.1 Allergan Migraine Basic Information
9.3.2 Allergan Migraine Product Overview
9.3.3 Allergan Migraine Product Market Performance
9.3.4 Allergan Migraine SWOT Analysis
9.3.5 Allergan Business Overview
9.3.6 Allergan Recent Developments
9.4 Amgen
9.4.1 Amgen Migraine Basic Information
9.4.2 Amgen Migraine Product Overview
9.4.3 Amgen Migraine Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Migraine Basic Information
9.5.2 Eli Lilly Migraine Product Overview
9.5.3 Eli Lilly Migraine Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Recent Developments
9.6 Teva Pharma
9.6.1 Teva Pharma Migraine Basic Information
9.6.2 Teva Pharma Migraine Product Overview
9.6.3 Teva Pharma Migraine Product Market Performance
9.6.4 Teva Pharma Business Overview
9.6.5 Teva Pharma Recent Developments
9.7 Biohaven Pharma
9.7.1 Biohaven Pharma Migraine Basic Information
9.7.2 Biohaven Pharma Migraine Product Overview
9.7.3 Biohaven Pharma Migraine Product Market Performance
9.7.4 Biohaven Pharma Business Overview
9.7.5 Biohaven Pharma Recent Developments
9.8 Abbott Laboratories
9.8.1 Abbott Laboratories Migraine Basic Information
9.8.2 Abbott Laboratories Migraine Product Overview
9.8.3 Abbott Laboratories Migraine Product Market Performance
9.8.4 Abbott Laboratories Business Overview
9.8.5 Abbott Laboratories Recent Developments
9.9 Johnson and Johnson
9.9.1 Johnson and Johnson Migraine Basic Information
9.9.2 Johnson and Johnson Migraine Product Overview
9.9.3 Johnson and Johnson Migraine Product Market Performance
9.9.4 Johnson and Johnson Business Overview
9.9.5 Johnson and Johnson Recent Developments
9.10 Valeant Pharma
9.10.1 Valeant Pharma Migraine Basic Information
9.10.2 Valeant Pharma Migraine Product Overview
9.10.3 Valeant Pharma Migraine Product Market Performance
9.10.4 Valeant Pharma Business Overview
9.10.5 Valeant Pharma Recent Developments
10 MIGRAINE MARKET FORECAST BY REGION
10.1 Global Migraine Market Size Forecast
10.2 Global Migraine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Migraine Market Size Forecast by Country
10.2.3 Asia Pacific Migraine Market Size Forecast by Region
10.2.4 South America Migraine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Migraine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Migraine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Migraine by Type (2025-2030)
11.1.2 Global Migraine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Migraine by Type (2025-2030)
11.2 Global Migraine Market Forecast by Application (2025-2030)
11.2.1 Global Migraine Sales (K Units) Forecast by Application
11.2.2 Global Migraine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Migraine Market Size Comparison by Region (M USD)
Table 5. Global Migraine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Migraine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Migraine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Migraine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2022)
Table 10. Global Market Migraine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Migraine Sales Sites and Area Served
Table 12. Manufacturers Migraine Product Type
Table 13. Global Migraine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Migraine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Migraine Market Challenges
Table 22. Global Migraine Sales by Type (K Units)
Table 23. Global Migraine Market Size by Type (M USD)
Table 24. Global Migraine Sales (K Units) by Type (2019-2024)
Table 25. Global Migraine Sales Market Share by Type (2019-2024)
Table 26. Global Migraine Market Size (M USD) by Type (2019-2024)
Table 27. Global Migraine Market Size Share by Type (2019-2024)
Table 28. Global Migraine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Migraine Sales (K Units) by Application
Table 30. Global Migraine Market Size by Application
Table 31. Global Migraine Sales by Application (2019-2024) & (K Units)
Table 32. Global Migraine Sales Market Share by Application (2019-2024)
Table 33. Global Migraine Sales by Application (2019-2024) & (M USD)
Table 34. Global Migraine Market Share by Application (2019-2024)
Table 35. Global Migraine Sales Growth Rate by Application (2019-2024)
Table 36. Global Migraine Sales by Region (2019-2024) & (K Units)
Table 37. Global Migraine Sales Market Share by Region (2019-2024)
Table 38. North America Migraine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Migraine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Migraine Sales by Region (2019-2024) & (K Units)
Table 41. South America Migraine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Migraine Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Migraine Basic Information
Table 44. Pfizer Migraine Product Overview
Table 45. Pfizer Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Migraine SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. GlaxoSmithKline Migraine Basic Information
Table 50. GlaxoSmithKline Migraine Product Overview
Table 51. GlaxoSmithKline Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Migraine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Allergan Migraine Basic Information
Table 56. Allergan Migraine Product Overview
Table 57. Allergan Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Allergan Migraine SWOT Analysis
Table 59. Allergan Business Overview
Table 60. Allergan Recent Developments
Table 61. Amgen Migraine Basic Information
Table 62. Amgen Migraine Product Overview
Table 63. Amgen Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. Eli Lilly Migraine Basic Information
Table 67. Eli Lilly Migraine Product Overview
Table 68. Eli Lilly Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recent Developments
Table 71. Teva Pharma Migraine Basic Information
Table 72. Teva Pharma Migraine Product Overview
Table 73. Teva Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Teva Pharma Business Overview
Table 75. Teva Pharma Recent Developments
Table 76. Biohaven Pharma Migraine Basic Information
Table 77. Biohaven Pharma Migraine Product Overview
Table 78. Biohaven Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Biohaven Pharma Business Overview
Table 80. Biohaven Pharma Recent Developments
Table 81. Abbott Laboratories Migraine Basic Information
Table 82. Abbott Laboratories Migraine Product Overview
Table 83. Abbott Laboratories Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Recent Developments
Table 86. Johnson and Johnson Migraine Basic Information
Table 87. Johnson and Johnson Migraine Product Overview
Table 88. Johnson and Johnson Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Recent Developments
Table 91. Valeant Pharma Migraine Basic Information
Table 92. Valeant Pharma Migraine Product Overview
Table 93. Valeant Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Valeant Pharma Business Overview
Table 95. Valeant Pharma Recent Developments
Table 96. Global Migraine Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Migraine Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Migraine Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Migraine Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Migraine Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Migraine Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Migraine Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Migraine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Migraine Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Migraine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Migraine Market Size Comparison by Region (M USD)
Table 5. Global Migraine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Migraine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Migraine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Migraine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2022)
Table 10. Global Market Migraine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Migraine Sales Sites and Area Served
Table 12. Manufacturers Migraine Product Type
Table 13. Global Migraine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Migraine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Migraine Market Challenges
Table 22. Global Migraine Sales by Type (K Units)
Table 23. Global Migraine Market Size by Type (M USD)
Table 24. Global Migraine Sales (K Units) by Type (2019-2024)
Table 25. Global Migraine Sales Market Share by Type (2019-2024)
Table 26. Global Migraine Market Size (M USD) by Type (2019-2024)
Table 27. Global Migraine Market Size Share by Type (2019-2024)
Table 28. Global Migraine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Migraine Sales (K Units) by Application
Table 30. Global Migraine Market Size by Application
Table 31. Global Migraine Sales by Application (2019-2024) & (K Units)
Table 32. Global Migraine Sales Market Share by Application (2019-2024)
Table 33. Global Migraine Sales by Application (2019-2024) & (M USD)
Table 34. Global Migraine Market Share by Application (2019-2024)
Table 35. Global Migraine Sales Growth Rate by Application (2019-2024)
Table 36. Global Migraine Sales by Region (2019-2024) & (K Units)
Table 37. Global Migraine Sales Market Share by Region (2019-2024)
Table 38. North America Migraine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Migraine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Migraine Sales by Region (2019-2024) & (K Units)
Table 41. South America Migraine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Migraine Sales by Region (2019-2024) & (K Units)
Table 43. Pfizer Migraine Basic Information
Table 44. Pfizer Migraine Product Overview
Table 45. Pfizer Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Migraine SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. GlaxoSmithKline Migraine Basic Information
Table 50. GlaxoSmithKline Migraine Product Overview
Table 51. GlaxoSmithKline Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Migraine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Allergan Migraine Basic Information
Table 56. Allergan Migraine Product Overview
Table 57. Allergan Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Allergan Migraine SWOT Analysis
Table 59. Allergan Business Overview
Table 60. Allergan Recent Developments
Table 61. Amgen Migraine Basic Information
Table 62. Amgen Migraine Product Overview
Table 63. Amgen Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. Eli Lilly Migraine Basic Information
Table 67. Eli Lilly Migraine Product Overview
Table 68. Eli Lilly Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recent Developments
Table 71. Teva Pharma Migraine Basic Information
Table 72. Teva Pharma Migraine Product Overview
Table 73. Teva Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Teva Pharma Business Overview
Table 75. Teva Pharma Recent Developments
Table 76. Biohaven Pharma Migraine Basic Information
Table 77. Biohaven Pharma Migraine Product Overview
Table 78. Biohaven Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Biohaven Pharma Business Overview
Table 80. Biohaven Pharma Recent Developments
Table 81. Abbott Laboratories Migraine Basic Information
Table 82. Abbott Laboratories Migraine Product Overview
Table 83. Abbott Laboratories Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Recent Developments
Table 86. Johnson and Johnson Migraine Basic Information
Table 87. Johnson and Johnson Migraine Product Overview
Table 88. Johnson and Johnson Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Recent Developments
Table 91. Valeant Pharma Migraine Basic Information
Table 92. Valeant Pharma Migraine Product Overview
Table 93. Valeant Pharma Migraine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Valeant Pharma Business Overview
Table 95. Valeant Pharma Recent Developments
Table 96. Global Migraine Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Migraine Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Migraine Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Migraine Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Migraine Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Migraine Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Migraine Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Migraine Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Migraine Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Migraine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Migraine Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Migraine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Migraine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Migraine Market Size (M USD), 2019-2030
Figure 5. Global Migraine Market Size (M USD) (2019-2030)
Figure 6. Global Migraine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Migraine Market Size by Country (M USD)
Figure 11. Migraine Sales Share by Manufacturers in 2023
Figure 12. Global Migraine Revenue Share by Manufacturers in 2023
Figure 13. Migraine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Migraine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Migraine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Migraine Market Share by Type
Figure 18. Sales Market Share of Migraine by Type (2019-2024)
Figure 19. Sales Market Share of Migraine by Type in 2023
Figure 20. Market Size Share of Migraine by Type (2019-2024)
Figure 21. Market Size Market Share of Migraine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Migraine Market Share by Application
Figure 24. Global Migraine Sales Market Share by Application (2019-2024)
Figure 25. Global Migraine Sales Market Share by Application in 2023
Figure 26. Global Migraine Market Share by Application (2019-2024)
Figure 27. Global Migraine Market Share by Application in 2023
Figure 28. Global Migraine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Migraine Sales Market Share by Region (2019-2024)
Figure 30. North America Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Migraine Sales Market Share by Country in 2023
Figure 32. U.S. Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Migraine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Migraine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Migraine Sales Market Share by Country in 2023
Figure 37. Germany Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Migraine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Migraine Sales Market Share by Region in 2023
Figure 44. China Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Migraine Sales and Growth Rate (K Units)
Figure 50. South America Migraine Sales Market Share by Country in 2023
Figure 51. Brazil Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Migraine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Migraine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Migraine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Migraine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Migraine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Migraine Market Share Forecast by Type (2025-2030)
Figure 65. Global Migraine Sales Forecast by Application (2025-2030)
Figure 66. Global Migraine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Migraine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Migraine Market Size (M USD), 2019-2030
Figure 5. Global Migraine Market Size (M USD) (2019-2030)
Figure 6. Global Migraine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Migraine Market Size by Country (M USD)
Figure 11. Migraine Sales Share by Manufacturers in 2023
Figure 12. Global Migraine Revenue Share by Manufacturers in 2023
Figure 13. Migraine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Migraine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Migraine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Migraine Market Share by Type
Figure 18. Sales Market Share of Migraine by Type (2019-2024)
Figure 19. Sales Market Share of Migraine by Type in 2023
Figure 20. Market Size Share of Migraine by Type (2019-2024)
Figure 21. Market Size Market Share of Migraine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Migraine Market Share by Application
Figure 24. Global Migraine Sales Market Share by Application (2019-2024)
Figure 25. Global Migraine Sales Market Share by Application in 2023
Figure 26. Global Migraine Market Share by Application (2019-2024)
Figure 27. Global Migraine Market Share by Application in 2023
Figure 28. Global Migraine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Migraine Sales Market Share by Region (2019-2024)
Figure 30. North America Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Migraine Sales Market Share by Country in 2023
Figure 32. U.S. Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Migraine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Migraine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Migraine Sales Market Share by Country in 2023
Figure 37. Germany Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Migraine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Migraine Sales Market Share by Region in 2023
Figure 44. China Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Migraine Sales and Growth Rate (K Units)
Figure 50. South America Migraine Sales Market Share by Country in 2023
Figure 51. Brazil Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Migraine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Migraine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Migraine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Migraine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Migraine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Migraine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Migraine Market Share Forecast by Type (2025-2030)
Figure 65. Global Migraine Sales Forecast by Application (2025-2030)
Figure 66. Global Migraine Market Share Forecast by Application (2025-2030)
